Skip to main content
Sign In

University of Colorado Cancer Center

University of Colorado Cancer Center, A National Cancer Institute-designated Comprehensive Cancer Center

David Norris, MD



Cell Growth, Death and Senescence, Signaling Pathways, and Oncogenes and Tumor Suppressor Genes, Gene Regulation and Transcription Factors, Tumor progression, invasion and metastasis, and Experimental and Molecular Therapeutics




University of Colorado Denver, Anschutz Medical Campus, Dept of Dermatology, Aurora   


3 Years of college 

Number of Openings: 1 


To better understand the progression and resistance to therapy of melanoma, and thus to find better treatment strategy


1) To examine the treatment potential of combining a small molecule inhibitor of Bcl-2 family members with conventional therapeutic agents to treat melanoma cells and melanoma-stem cells.

2) To explore the roles of miRNAs in melanoma tumorigenesis and therapeutic potential of miRNA in melanoma treatment. 


© The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.